![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 3
2023
Hemmer, Bernhard; Wiendl, Heinz; Roth, Karsten; Wessels, Hendrik; Hoefler, Josef; Hornuss, Cyrill; Liedert, Bernd und Selmaj, Krzysztof
(2023):
Efficacy and Safety of Proposed Biosimilar Natalizumab (PB006) in Patients With Relapsing-Remitting Multiple Sclerosis The Antelope Phase 3 Randomized Clinical Trial.
In: JAMA Neurology, Bd. 80, Nr. 3: S. 298-307
[PDF, 462kB]
2016
Colin, Pieter; Eleveld, Douglas J.; Berg, Johannes P. van den; Vereecke, Hugo E. M.; Struys, Michel M. R. F.; Schelling, Gustav; Apfel, Christian C. und Hornuss, Cyrill
(2016):
Propofol Breath Monitoring as a Potential Tool to Improve the Prediction of Intraoperative Plasma Concentrations.
In: Clinical Pharmacokinetics, Bd. 55, Nr. 7: S. 849-859
2014
Zoller, Michael; Maier, Barbara; Hornuss, Cyrill; Neugebauer, Christina; Döbbeler, Gundula; Nagel, Dorothea; Holdt, Lesca Miriam; Bruegel, Mathias; Weig, Thomas; Grabein, Béatrice; Frey, Lorenz; Teupser, Daniel; Vogeser, Michael und Zander, Johannes
(2014):
Variability of linezolid concentrations after standard dosing in critically ill patients: a prospective observational study.
In: Critical Care
18:R148
[PDF, 961kB]